Cargando…

Comparable Clinical Outcome Using Small or Large Gross Tumor Volume-to-Clinical Target Volume Margin Expansion in Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

The purpose of this study was to evaluate the feasibility of small primary gross tumor volume (GTV)-to-clinical target volume (CTV) margin expansion in neoadjuvant chemoradiation for esophageal squamous cell carcinoma. Medical records of 139 patients with locally advanced esophageal squamous cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Tae Hoon, Kim, Hak Jae, Kim, Byoung Hyuck, Kang, Chang Hyun, Keam, Bhumsuk, Moon, Hyeon Jong, Seong, Yong Won, Kim, Suzy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187480/ https://www.ncbi.nlm.nih.gov/pubmed/35693980 http://dx.doi.org/10.1155/2022/5635071

Ejemplares similares

Gross Tumor Volume Predicts Survival and Pathological Complete Response of Locally Advanced Esophageal Cancer After Neoadjuvant Chemoradiotherapy
por: Wang, Rong, et al.
Publicado: (2022)

Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2022)

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy
por: Hulshoff, J. B., et al.
Publicado: (2015)

The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
por: Park, Seong Yong, et al.
Publicado: (2020)

Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy
por: Zhang, Cui-Dai, et al.
Publicado: (2021)

Deep Learning for Automated Contouring of Gross Tumor Volumes in Esophageal Cancer
por: Jin, Linzhi, et al.
Publicado: (2022)

Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma
por: Park, Younghee, et al.
Publicado: (2023)

Efficacy of Prophylactic Cranial Irradiation According to the Risk of Extracranial Recurrence in Limited-Stage Small Cell Lung Cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)

Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancer
por: Koo, Taeryool, et al.
Publicado: (2022)

Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy
por: Kim, Byoung Hyuck, et al.
Publicado: (2023)

Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer
por: Shin, Jung Kyong, et al.
Publicado: (2022)

Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer
por: Chen, Yuanmei, et al.
Publicado: (2021)

Effect of circumferential resection margin status on survival and recurrence in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
por: Gu, Yi-Min, et al.
Publicado: (2022)

Prognosticating Gross Tumor Volume in Head-and-Neck Cancer – Redefining Gross Tumor Volume Beyond Contouring
por: Ahmed, Imtiaz, et al.
Publicado: (2023)

The Effects of the Shape and Size of the Clinical Target Volume on the Planning Target Volume Margin
por: Zheng, Buhong, et al.
Publicado: (2014)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
por: Anvari, Kazem, et al.
Publicado: (2015)

The Key Clinical Questions of Neoadjuvant Chemoradiotherapy for Resectable Esophageal Cancer—A Review
por: Han, Dan, et al.
Publicado: (2022)

Chemoradiotherapy With or Without Surgery for Esophageal Squamous Cancer According to Hospital Volume
por: Duarte, Mateus Bringel Oliveira, et al.
Publicado: (2020)

Comparison of the Gross Target Volumes Based on Diagnostic PET/CT for Primary Esophageal Cancer
por: Shi, Jingzhen, et al.
Publicado: (2021)

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2018)

Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2022)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
por: Gao, Hui‐Jiang, et al.
Publicado: (2020)

Neoadjuvant chemoradiotherapy followed by resection for esophageal cancer: clinical outcomes with the ‘CROSS-regimen’ in daily practice
por: Cloos-v.Balen, Marissa, et al.
Publicado: (2021)

Failure patterns of cervical lymph nodes in metastases of unknown origin according to target volume
por: Kim, Dong-Yun, et al.
Publicado: (2020)

Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
por: Ai, Dashan, et al.
Publicado: (2023)

Subclinical Lesions of the Primary Clinical Target Volume Margin in Esophageal Squamous Cell Carcinoma and Association With FDG PET/CT
por: Han, Dali, et al.
Publicado: (2019)

Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
por: Kim, Yong-Hyub, et al.
Publicado: (2015)

The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma
por: Park, Seong Yong, et al.
Publicado: (2023)

Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses
por: Wijnhoven, Bas P. L., et al.
Publicado: (2009)

Neoadjuvant Chemoradiotherapy and Larynx-Preserving Surgery for Cervical Esophageal Cancer
por: Dai, Kun-Yao, et al.
Publicado: (2020)

Clinical Factors to Predict the Response to Concurrent Chemoradiotherapy and Survival in Esophageal Cancer Patients
por: Nam, Su Youn, et al.
Publicado: (2020)

Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinoma
por: Shi, Yu, et al.
Publicado: (2019)

Changes in cardiac volume determined with repeated enhanced 4DCT during chemoradiotherapy for esophageal cancer
por: Wang, Xue, et al.
Publicado: (2018)

Esophageal cancer treated by endoscopic submucosal dissection after neoadjuvant chemoradiotherapy: a case report
por: Lim, Jang Hwan, et al.
Publicado: (2014)

The clinical application of 4D (18)F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer
por: Wang, Yao-Ching, et al.
Publicado: (2012)

Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients
por: Jung, Ji-Han, et al.
Publicado: (2016)

Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
por: Yun, Jae Kwang, et al.
Publicado: (2022)

Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma
por: Kwon, Dohee, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8mcvp8h3io4rdq6gulqp750vo3